Key Financial Data Of Reporting Company

Fuso Pharmaceutical Industries,Ltd. - Filing #7737865

Concept 2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2017-03-31
2016-04-01 to
2017-03-31
As at
2016-03-31
As at
2016-03-31
2015-04-01 to
2016-03-31
2015-04-01 to
2016-03-31
2014-04-01 to
2015-03-31
2014-04-01 to
2015-03-31
As at
2015-03-31
As at
2015-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2013-04-01 to
2014-03-31
As at
2014-03-31
2012-04-01 to
2013-03-31
As at
2013-03-31
As at
2013-03-31
2012-04-01 to
2013-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
46,782,000,000 JPY
JPY
45,752,000,000 JPY
JPY
47,042,000,000 JPY
JPY
49,098,000,000 JPY
JPY
48,612,000,000 JPY
48,581,000,000 JPY
Ordinary profit (loss)
642,000,000 JPY
JPY
172,000,000 JPY
JPY
678,000,000 JPY
JPY
2,741,000,000 JPY
JPY
3,764,000,000 JPY
3,747,000,000 JPY
Profit (loss)
861,000,000 JPY
10,000,000 JPY
340,000,000 JPY
1,979,000,000 JPY
4,871,000,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
10,758,000,000 JPY
Total number of issued shares
9,451,169 xbrli:shares
94,511,690 xbrli:shares
94,511,690 xbrli:shares
94,511,690 xbrli:shares
94,511,690 xbrli:shares
Net assets
JPY
32,545,000,000 JPY
JPY
32,616,000,000 JPY
33,538,000,000 JPY
JPY
JPY
34,892,000,000 JPY
33,789,000,000 JPY
33,097,000,000 JPY
Total assets
JPY
68,788,000,000 JPY
JPY
69,056,000,000 JPY
68,627,000,000 JPY
JPY
JPY
68,644,000,000 JPY
71,845,000,000 JPY
71,849,000,000 JPY
Net assets per share
3,642.78
3,606.75
3,707.67
3,856.08
3,732.50
3,656.12
Dividend paid per share
44.00
8.00
8.00
8.00
8.00
Interim dividend paid per share
4.00
4.00
4.00
4.00
3.00
Basic earnings (loss) per share
95.86
1.12
37.67
218.67
538.11
538.12
Diluted earnings per share
Equity-to-asset ratio
xbrli:pure
0.473 xbrli:pure
xbrli:pure
0.472 xbrli:pure
0.489 xbrli:pure
xbrli:pure
xbrli:pure
0.508 xbrli:pure
0.470 xbrli:pure
0.461 xbrli:pure
Rate of return on equity
0.026 xbrli:pure
xbrli:pure
0.000 xbrli:pure
xbrli:pure
0.010 xbrli:pure
xbrli:pure
0.058 xbrli:pure
xbrli:pure
0.163 xbrli:pure
0.160 xbrli:pure
Price-earnings ratio
29.3 xbrli:pure
xbrli:pure
2,327.1 xbrli:pure
xbrli:pure
82.6 xbrli:pure
xbrli:pure
16.6 xbrli:pure
xbrli:pure
7.7 xbrli:pure
7.7 xbrli:pure
Payout ratio
0.835 xbrli:pure
71.604 xbrli:pure
2.124 xbrli:pure
0.366 xbrli:pure
0.149 xbrli:pure
Net cash provided by (used in) operating activities
1,876,000,000 JPY
JPY
2,117,000,000 JPY
JPY
1,943,000,000 JPY
JPY
2,889,000,000 JPY
JPY
3,258,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-786,000,000 JPY
JPY
-5,336,000,000 JPY
JPY
-2,890,000,000 JPY
JPY
-1,779,000,000 JPY
JPY
2,416,000,000 JPY
JPY
Net cash provided by (used in) financing activities
-1,145,000,000 JPY
JPY
2,326,000,000 JPY
JPY
-955,000,000 JPY
JPY
-2,425,000,000 JPY
JPY
-832,000,000 JPY
JPY
Cash and cash equivalents
JPY
4,951,000,000 JPY
JPY
5,006,000,000 JPY
5,898,000,000 JPY
JPY
JPY
7,801,000,000 JPY
JPY
9,120,000,000 JPY
Number of employees
xbrli:pure
1,374 xbrli:pure
xbrli:pure
1,362 xbrli:pure
1,385 xbrli:pure
xbrli:pure
xbrli:pure
1,366 xbrli:pure
1,370 xbrli:pure
1,370 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.